Aura Biosciences, Inc. (AURA) stock
AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.11−0.50 (-6.57%)
Close on Nov 12, 2026Market cap $737.34MP/E –Yield –
Aura Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Aura Biosciences's enterprise value was $719.65M on Nov 11, 2026, against $368.15M a year earlier. Over the last 5 years it ranged from -$74.31M to $719.65M, with a median of $304.09M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $719.65M | +143.4% |
| 2025 | Dec 31, 2025 | $295.72M | -22.9% |
| 2024 | Dec 31, 2024 | $383.78M | +102.5% |
| 2023 | Dec 29, 2023 | $189.50M | -3.3% |
| 2022 | Dec 30, 2022 | $195.97M | – |
| 2021 | Dec 31, 2021 | -$74.31M | – |
See a number that looks wrong?